Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors

por Kim, Hark Kyun, Kang, Jeong Won, Park, Young‐Whan, Kim, Jung Young, Kim, Minchae, Kim, Soo Jin, Kim, Se‐mi, Ho Ryu, Keun, Yoon, Seonghae, Kim, Yun, Cho, Joo‐Youn, Lee, Keun Seok, Yun, Tak, Kim, Kiwon, Kwak, Mi Hyang, Kim, Tae‐Sung, Chung, Jinsoo, Park, Joong‐Won
Publicado 2020